Replicam provides Brain OPTIMA™, an integrated brain microphysiological system that delivers vascular‑mimic internal flow to support extra‑large, multi‑region neural organoids—up to five times larger than competing models. The platform offers ready‑to‑use, cryopreserved organoids with 90% long‑term viability and plug‑and‑play compatibility with standard lab equipment, enabling faster, human‑relevant data for disease research, drug discovery, and AI‑driven biocomputing.
Funding
Funding not disclosed
Founders
Product
Problem
Traditional brain organoid models are limited in size and lack internal vascular-like perfusion, leading to necrotic cores, low viability, and poor scalability for drug discovery and disease research.
Solution
Replicam’s Brain OPTIMA™ is an integrated brain microphysiological system that provides vascular‑mimic internal flow, enabling the culture of extra‑large, multi‑region neural organoids up to five times larger than competing models. The platform delivers plug‑and‑play, cryopreserved organoids with over 90% long‑term viability and rapid recovery (<1 hour) for assay‑ready use. Standard laboratory equipment can be used for data collection, while dedicated bioinformatics translates results to in‑vivo relevance, supplying high‑fidelity, human‑relevant data for drug discovery, disease modeling, and AI‑driven biocomputing.
Target Audience
Primary customers are pharmaceutical and biotech companies, academic research labs, and AI/biocomputing teams that require scalable, high‑fidelity human brain models for drug screening, disease research, and personalized medicine.
Features
- Internal perfusion system that mimics vascular flow, preventing necrotic cores and supporting >90% long‑term viability
- Cryopreservation workflow delivering >85% immediate recovery and <1 hour turnaround to assay‑ready state
- Modular, plug‑and‑play design compatible with standard lab instruments for seamless data acquisition
- Multi‑regional 3D brain/CNS organoids >5× larger than existing models, enabling more comprehensive neural network studies
- Organoid‑specific bioinformatics pipeline that maps in‑vitro results to in‑vivo relevance for drug kinetics and disease modeling